Detailed study results will be presented at an upcoming medical meeting and submitted to health authorities later this year to expand Palynziq’s label to include adolescents.

Washington DC - Almost six years ago, Fatiha and Abellatif Abderraziq stood in the parking lot of Washington children’s ...

Phenylalanine is an essential amino acid (building block of protein) that the body doesn't produce, meaning it must be obtained through food. It is found in protein-rich foods. Your body uses ...

BioMarin has reported that the multi-centre Phase III PEGASUS trial of Palynziq (pegvaliase-pqpz) has met its primary ...

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) released topline data from the Phase 3 PEGASUS trial evaluating Palynziq ...

BioMarin Pharmaceutical Inc. has advancements in phenylketonuria treatment. Click to learn how Palynziq's success could ...

BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that the Phase 3 PEGASUS trial evaluating PALYNZIQ® (pegvaliase-pqpz) met its primary efficacy endpoint, demonstrating a statistically ...

One of the most significant challenges facing current nanozyme technologies is the lack of well-defined active sites, which ...

San Rafael, California Thursday, April 3, 2025, 18:00 Hrs [IST] ...

Researchers are developing new approaches to detect and treat cancer in smarter, safer and kinder ways.